Press Releases

Date Title and Summary Additional Formats
Toggle Summary Omnicell Announces Preliminary Fiscal Year 2020 Financial Results
Company Expects to Exceed Previously Announced Guidance Across All Key Metrics; Provides Full Year 2021 Guidance and Updates Long-Term Targets 2020 Total Product Bookings Expected to be Approximately $1.00 Billion and 2020 Revenues Expected to be $890 Million-$892 Million   Increased Full Year 2021...
View HTML
Toggle Summary Omnicell's EnlivenHealth™ Reports Strong Customer Demand for New SaaS Technology Solution to Help Pharmacies Meet COVID-19 Vaccination Challenges
CareScheduler Automates Vaccine Scheduling, Consent Collection, Registry Reporting and Patient Outreach; Enables Pharmacies to Efficiently Administer COVID-19 Vaccine MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jan. 11, 2021-- Omnicell, Inc. , (Nasdaq:OMCL), a leading provider of medication management...
View HTML
Toggle Summary Omnicell to Partner with Guy’s and St Thomas’ NHS Foundation Trust, London on Development of European Technology-Enabled Intelligence Centre as Part of Expansion of Omnicell Systems Across the South East London NHS Integrated Care System
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jan. 4, 2021-- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and supply chain solutions for health systems, today announced its intent to enter a new partnership with Guy’s and St Thomas’ NHS Foundation Trust , London to develop...
View HTML
Toggle Summary Owensboro Health to Deploy Omnicell’s Technology-Enabled Services to Improve Safety and Efficiency in Medication Management
Partnership Extends Medication Management Platform to Central Pharmacy Operations MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 21, 2020-- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that...
View HTML
Toggle Summary Omnicell to Present at the J.P. Morgan 39th Annual Healthcare Conference
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 15, 2020-- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences: Randall Lipps ,...
View HTML
Toggle Summary New National Survey Finds the Majority of Retail Pharmacies and Health Plans Are Concerned About People Actually Taking the COVID-19 Vaccine Once It’s Available
EnlivenHealth™ Launches CareScheduler Solution to Enable Pharmacies to Provide Hands-Free Scheduling, Consent and Registry Reporting for COVID-19 Vaccine, Reducing Infection Risk for Patients and Staff RALEIGH, N.C. --(BUSINESS WIRE)--Nov. 11, 2020-- EnlivenHealth™, a division of Omnicell, Inc....
View HTML
Toggle Summary Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services at Omnicell Illuminate 2020
Winter 2020 Release Delivers Innovation to Support the Autonomous Pharmacy Journey to Zero-Error Medication Management MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Nov. 10, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems...
View HTML
Toggle Summary Allegheny Health Network Partners with Omnicell to Drive Safety and Efficiency for Medication Management Across Western Pennsylvania Network
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Nov. 9, 2020-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management and supply chain solutions for health systems, today announced a new partnership with Allegheny Health Network (AHN), to provide central pharmacy dispensing and...
View HTML
Toggle Summary Omnicell to Present at Upcoming Investor Conferences
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Nov. 6, 2020-- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences: Peter Kuipers , Omnicell...
View HTML
Toggle Summary Omnicell Reports Third Quarter 2020 Results
GAAP and non-GAAP revenues of $213.7 million GAAP net income per diluted share of $0.20 Non-GAAP net income per diluted share of $0.60 MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Oct. 27, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for...
View HTML